C15 (pentadecanoic acid), a saturated fat with 15 carbons, is the first new essential fatty acid discovered in 90 years, identified through Navy dolphins that aged healthily with higher C15 levels.
2
C15 meets all criteria for essentiality (deficiency syndrome, dietary need, independent gold-standard validation) and works as a geroprotector by activating AMPK, inhibiting mTOR, stabilizing cell membranes against lipid peroxidation, and even forming a second endocannabinoid (PDC) that activates CB1/CB2 receptors for improved sleep, mood, and pain.
3
Human epidemiology shows each 50% higher C15 level reduces type-2 diabetes risk by 8% and coronary heart disease risk by 17%; clinical trials in fatty liver disease showed improved liver enzymes and hemoglobin, though adherence issues highlight the need for proper dosing and longer studies.
4
Primary food sources are grass-fed full-fat dairy and especially high-altitude grass-fed cheeses (like Sardinian pecorino), but because whole dairy also contains pro-inflammatory even-chain fats, a pure C15 supplement (Fatty15, 100 mg capsules) allows precise dosing of 100–300 mg/day with 100% bioavailability, with pre/post blood testing recommended after 3–6 months.
Protocols
Concrete recipes — what, when, how much, and why
3 items
C15 supplementation protocol (pure C15 as fatty acid)
WhatTake a pure C15 supplement (free fatty acid form, e.g., Fatty15) at 100–300 mg per day. Start with one 100 mg capsule and titrate up if needed. Consider a loading phase if C15 deficient.
WhenDaily, with or without food; can be taken any time of day.
Dose100–300 mg/day; 100 mg per capsule; studies used 200 mg for 12 weeks in deficiency. She suggests 3–6 months for re-testing.
For whomAnyone avoiding full-fat dairy, those with fatty liver, metabolic syndrome, or low C15 levels (<5 µg/mL), and individuals seeking longevity support. The speaker (and host) personally use it.
WhyTo correct a common nutritional deficiency of C15, restore cell membrane stability, activate AMPK/mTOR pathways, support endocannabinoid tone, and lower risk of type-2 diabetes, heart disease, and fatty liver disease.
CaveatsAdherence is key; increases in blood C15 were seen only in those who took the supplement consistently. Effects are not immediate; retest after 3–6 months. Not a substitute for exercise or calorie restriction but can enhance them.
The dosage recommendation comes from pharmacokinetic studies showing 100% bioavailability for this free fatty acid form, with each 100 mg raising blood C15 by about 1 µg/mL. The target is to exceed the deficiency threshold of 5 µg/mL; many people are far below that. Clinical trials in fatty liver disease patients found that 200 mg/day restored C15 levels and improved liver enzymes in adherent participants. The 300 mg dose was also studied. Because C15 is an essential fatty acid, the body self-regulates usage; stored C15 is converted to PDC on demand, so there is minimal risk of overdose. Dr. Venn-Watson recommends pre-supplementation blood work (C15 level, CBC, liver enzymes, ferritin, RDW) and a follow-up at 3–6 months to confirm repletion and clinical improvements. The host, Ben Greenfield, self-experiments with 4 capsules (400 mg) due to his larger muscle mass and dairy intolerance, though that exceeds typical dosing.
Mechanism
C15 incorporates into cell membranes, increasing resistance to lipid peroxidation. It activates AMPK and AKT while inhibiting mTOR and other pro-aging pathways, mimicking exercise and metformin/rapamycin. Additionally, C15 is metabolized to pentadecanoylcarnitine (PDC), a full agonist at CB1 and CB2 cannabinoid receptors, explaining its rapid effects on sleep, mood, and pain.
Personal experience
Ben Greenfield: 'I'm 2 months into kind of trialing using C15 via this supplement called Fatty 15. So I've been taking … four of those a day.' He notes he is lactose intolerant and avoids dairy. Dr. Venn-Watson reports personal benefits: deeper sleep, calmer mood, less joint pain.
We have over a 95% monthly retention rate and it's not because you know people are just crossing their fingers and believing … they're seeing and feeling benefits within months.
Also said
“For every 100 milligrams you eat you go up by one microgram. gram per mill.”— Explains the dose-response used to guide supplementation.
“Get your standard CBC and CAM go back. We say we recommend between 3 to 6 months later.”— Provides the recommended retest interval.
C15 blood testing protocol (Genova Diagnostics)
WhatOrder an at-home dried blood spot test from Genova Diagnostics (or ask physician for a fatty acid panel that includes C15).
WhenBefore starting C15 supplementation and 3–6 months after.
DoseSingle test, repeated.
For whomAnyone considering C15 supplementation or with risk factors for metabolic disease.
WhyTo diagnose C15 deficiency (<5 µg/mL) and track repletion; also to monitor changes in RBC indices (RDW) and other markers.
CaveatsInsurance may not cover; the test uses a different reference range than some labs. Must ensure C15 is included in the fatty acid panel.
Because C15 was historically used only as a dairy-fat biomarker, many standard fatty acid panels before the 1990s did not include it. Today, many panels do, but it is critical to confirm. Dr. Venn-Watson collaborated with Genova to create an accessible at-home test. She personally used it and achieved ‘Sardinian-level’ C15 (>5 µg/mL, around 46th percentile in her reference). The test measures C15 in micrograms per milliliter using a blood spot. She also advises to ask for ferritin and full RBC indices including RDW (red blood cell distribution width), which is a validated aging-rate biomarker that C15 has been shown to reduce.
Personal experience
Dr. Venn-Watson: 'That's where I was able to show that my C-15 levels … in that test … showed … the Sardinian level. So 46% and over five uh micrograms per mill.'
If people don't have an option, … then you can get this at home blood spot test and then … mail it in and they send you your results.
Also said
“A higher C-15, the lower the risk of um developing type 2 diabetes.”— Context for why testing is valuable.
Grass-fed dairy and high-altitude cheese consumption
WhatPrioritize full-fat dairy from grass-fed animals, especially cheeses from sheep/goats grazed at high altitude (e.g., Sardinian pecorino).
WhenAs part of regular diet, in moderation.
DoseA few servings per week; not to exceed 90% of diet.
For whomPeople who tolerate dairy and want to increase C15 intake naturally.
WhyGrass-fed dairy has up to twice the C15 of conventional, and high-altitude grazing adds further C15 density; the Sardinian longevity zone exemplifies this dietary pattern.
CaveatsWhole dairy also contains pro-inflammatory even-chain saturated fats (C16, C18), so don't overconsume; those with lactose intolerance or dairy sensitivity may not tolerate it. Supplementation offers a way to get C15 without the even-chain fats.
Dr. Venn-Watson emphasized that the Sardinian Blue Zone’s longevity is partly linked to replacing meat with cheese made from grass-fed, high-altitude-grazing sheep and goats. This cheese has 50% more C15 than other dairy. She does not avoid whole dairy entirely but practices moderation. The confounding factor is that whole dairy is a mixed bag of fats — while it supplies C15, the higher levels of C16 and C18 can promote inflammation, which is why Bishop et al. found that giving whole dairy fat to a diabetic mouse model worsened outcomes, whereas pure C15 improved them. Therefore, she recommends selecting the highest C15 dairy (grass-fed, high-altitude if possible) and using it as a complement, not a dominant calorie source.
When I'm going for my whole dairy fat options, I go for cheeses … from … grass-fed animals.
Also said
“In Sardinia, the cheese that they eat is special because that cheese is coming from grass-fed animals.”— Reinforces the geographic specificity.
What's new
Personal practice updates, fresh positions, predictions
5 items
C15 is the first new essential fatty acid discovered in 90 years
Dr. Venn-Watson’s team, while studying Navy dolphins, found that the odd-chain saturated fat C15 (pentadecanoic acid) meets the strict criteria of an essential fatty acid — something not achieved since the discovery of omega-3 and omega-6 in 1929/1931.
Why this matters: This overturns the long-held assumption that all essential fatty acids were known and that saturated fats are universally harmful. Four independent teams have since replicated the essentiality criteria in gold-standard depletion–repletion models, including maternal deprivation and worm studies.
Background
Previously, only two essential fatty acids were recognized: alpha-linolenic acid (omega-3) and linoleic acid (omega-6). C15 had been used merely as a biomarker of dairy fat intake, never as a bioactive nutrient itself.
The discovery was accidental: the U.S. Navy wanted to understand why aging dolphins, despite a pristine fish diet, developed metabolic syndrome, fatty liver, and even Alzheimer’s-like changes. Metabolomics on archived dolphin serum and their all-fish diet revealed that higher C15, not omega-3s, predicted the healthiest aging. This led to eight studies over three years, resulting in a 2020 paper in Scientific Reports (senior author Dr. Ed Dennis) demonstrating C15 meets essential fatty acid criteria. Subsequently, independent groups performed the exact 1929 Burr mouse deprivation model, where pregnant mice were deprived of C15, causing growth failure in offspring that reversed upon C15 repletion, and a worm model where C15 alone restored normal growth after removal of all nutrients. These add robust external validation.
We showed that C-15 is not only a beneficial and active saturated fat but that it was meeting these rare criteria of being an essential fatty acid.
Also said
“Four independent teams have now looked at the criteria of C15 being an essential fatty acid including gold standard studies that were used back in 1929 and 1931… all concluding that yes, C15 meets the criteria of an essential fatty acid.”— Provides third-party confirmation that the essentiality finding has been replicated.
“They demonstrated nutritional deficiency syndrome, so poor growth. And when they gave the babies C-15, their growth restored.”— Describes the gold-standard mouse model that sealed the case for essentiality.
Dolphin aging as a model for human chronic disease
Navy dolphins living into their 40s–60s develop insulin resistance, fatty liver, anemia, chronic inflammation, and even Alzheimer’s-like pathology on a pure fish diet, implicating a missing nutrient rather than junk food.
Why this matters: It flips the narrative on lifestyle diseases: these dolphins got metabolic syndrome without carbs, seed oils, or alcohol, challenging the idea that those are the sole causes and pointing to a deficiency.
Background
Wild dolphins live about 20 years; Navy dolphins with excellent veterinary care live 2–3 times longer, affording a natural aging study.
The Navy’s population of ~100 bottlenose dolphins in San Diego Bay provides an unprecedented aging cohort. Despite a controlled all-fish diet and daily open-ocean activity, one in three older dolphins developed the same chronic conditions seen in humans. This led Dr. Venn-Watson to consult human experts, who immediately recognized the parallel. The key insight was that these dolphins, lacking processed food, pointed to an absence of something rather than an excess. Metabolomics of archived serum (going back decades) and their fish diet zeroed in on C15 as the single molecule that discriminated healthy agers from those with disease. This comparative veterinary epidemiology provided the initial clue that C15 might be essential.
One in three older Navy dolphins were developing things that are going to sound really familiar like insulin resistance, fatty liver disease, high cholesterol, anemia, chronic inflammation, and as we just published last week, the full suite of changes consistent with Alzheimer's.
Also said
“Despite being Navy dolphins, they they also are not not heavy drinkers.”— Underscores that alcohol and poor diet were absent, making the disease similarities all the more striking.
C15 as a geroprotector meeting five longevity-molecule must-haves
Dr. Nick Schork of the NIH longevity consortium defined five criteria for a geroprotector — targeting longevity pathways, hallmarks of aging, slowing aging rate, delivering clinical benefits in months, and preventing disease — and concluded C15 meets all five.
Why this matters: This framework elevates C15 from a simple fatty acid to a potential anti-aging molecule on par with rapamycin and metformin, but derived from diet rather than a drug.
Schork reviewed the accumulating 100+ peer-reviewed studies on C15 and articulated that a true geroprotector must do more than just reduce disease risk; it must slow the underlying rate of biological aging. The five must-haves are: (1) targeting the human longevity-regulating pathway (AMPK activation/mTOR inhibition, same as metformin and rapamycin), (2) targeting key hallmarks of aging (improved mitochondrial function, fewer senescent cells, reduced inflammaging), (3) evidence of slowing the aging rate (C15 repeatedly lowers red blood cell distribution width, RW, a validated aging-rate biomarker), (4) clinically relevant benefits within months (seen in liver enzymes, hemoglobin, and subjective reports), and (5) strong evidence for disease prevention (meta-analyses of tens of thousands of people show higher C15 lowers risk of type-2 diabetes, heart disease, and fatty liver disease). He stated no molecule has more support for this role than C15.
Personal experience
Host Ben Greenfield has personally started taking C15 and reports being two months into a trial with perceived benefits, though not yet quantified.
Nick said, 'Steve, like C-15 is the evidence I'm seeing is that C-15 is emerging as a ger protector.' … A ger protector is the holy grail of a longevity molecule because it slows the rate at which we age to stem the onset of the diseases that kill us.
Also said
“It activates EMPK and inhibits mTor. Right? This is what metformin and rapamy do respectively.”— Shows direct mechanistic comparison to leading anti-aging drugs.
“For every 50% incremental increase in C-15 the percentage that we have in our … blood decreases our risk of type 2 diabetes by 8% and … coronary heart disease by 17%.”— Quantifies the disease-prevention evidence.
C15 is a precursor to a newly discovered endocannabinoid (PDC) that explains mood, sleep, and pain benefits
C15’s metabolite, pentadecanoylcarnitine (PDC), fully activates CB1 and CB2 cannabinoid receptors, making it only the second known endogenous full agonist of these receptors, which explains the rapid reports of deeper sleep, calmer mood, and reduced joint pain within two weeks of supplementation.
Why this matters: This reveals a direct biochemical link between a dietary fat and the endocannabinoid system, providing a natural, demand-driven cannabinoid tone without exogenous cannabis.
When early users of pure C15 (Fatty15) reported rapid improvements in sleep, mood, and joint discomfort, the effects didn’t fit the known mechanisms. Subsequent research found that the body converts C15 into PDC, and receptor-binding assays showed PDC fully activates both CB1 (central nervous system) and CB2 (immune/peripheral) cannabinoid receptors. This is significant because, prior to this, only one full endogenous cannabinoid (anandamide-like) was known. The body makes PDC on demand from stored C15, so the effect is self-regulating, unlike the acute spike from cannabis edibles. This also suggests C15 could be used to support endocannabinoid tone and potentially help people taper off exogenous cannabinoids.
Personal experience
Dr. Venn-Watson herself experienced deeper sleep, calmer mood, and less joint pain, which she now understands through this mechanism.
This PDC was the second so the second ever discovered which then helped explain aha deeper sleep calmer mood less joint pain all of which I have experienced myself.
Also said
“PDC fully activated CB-1 and CB2 receptors where CB stands for canabonoid so these are the receptors throughout our brain and body that respond to cannabis.”— Clarifies the direct receptor activation.
“Our bodies make it on demand so we store C-15 and then when our bodies need less pain calmer mood better sleep, our bodies will actually then make the… endockinabonoid.”— Explains why the effect is physiological and not like a drug hit.
Sardinian high-altitude grass-fed cheese as a natural C15 powerhouse
Sardinian longevity-zone cheese, particularly pecorino from sheep and goats grazed on high-altitude grass, contains 50% more C15 than other dairy and contributes to the population’s 2–3× higher blood C15 levels.
Why this matters: It offers a food-based blueprint for optimizing C15 intake and explains a piece of the Blue Zone longevity puzzle beyond just diet composition.
Dr. Venn-Watson highlighted that the Sardinian Blue Zone diet swaps meat for cheese, and their specific cheese — from sheep and goats grazing on high-altitude pastures — is uniquely rich in C15. Grass-fed animals in general produce milk with twice the C15 of corn-fed cows, but altitude adds an additional stress that may further upregulate C15 in the milk (hypothesis: C15 helps plants and animals cope with hypoxia). This provides a plausible mechanism for the observed longevity advantage. However, she cautions that whole dairy also brings pro-inflammatory even-chain saturated fats (C16, C18), so the Sardinians’ practice of using cheese as the primary protein rather than meat and the high C15 content of their specific cheese may be the key, not all dairy.
The Sardinian high longevity zone is in a mountainous region in Sardinia… grass-eating sheep and goats at high altitude … resulting in their cheese … has 50% more C15 in it compared to other dairy fats.
Also said
“People in this high longevity zone have two to three times higher C-15 levels than the rest of us.”— Quantifies the human exposure difference.
“Grass-fed animals have twice as much C15 in it than, um, like cows, for example, that are fed corn.”— Gives a actionable diet rule of thumb.
Recommendations
Products, supplements, and tools mentioned in the episode
2 items
Genova Diagnostics at-home C15 blood spot test
Tool
An at-home dried blood spot test to measure C15 levels and monitor deficiency/repletion.
This test was developed specifically because most standard fatty acid panels historically omitted C15. It provides a user-friendly way to check C15 status without a doctor’s visit. Dr. Venn-Watson used it herself and confirmed her level was in the Sardinian range. She suggests pairing it with standard blood work (CBC, CMP) to track additional markers like RDW and liver enzymes.
vs alternatives
Compared to asking a physician for a fatty acid panel that includes C15, this test is convenient and guaranteed to include C15, since many panels may not.
Personal experience
Dr. Venn-Watson used this test to confirm her C15 level: 'So 46% and over five uh micrograms per mill.'
We worked with Genova Diagnostics to develop an atome blood spot test.
Dietary practice to increase C15 intake naturally by choosing cheese from grass-fed sheep/goats, especially from mountainous regions (e.g., Sardinian pecorino).
This recommendation emerges from the observation that Sardinian longevity-zone residents have 2–3× higher C15 levels due to their cheese. The key variables are grass-fed and high altitude, both of which independently increase milk C15. Dr. Venn-Watson does not shy away from whole dairy in moderation but emphasizes choosing these higher C15 options. This practice is suggested as an adjunct, not a replacement for supplementation especially for those who avoid dairy or need higher doses.
vs alternatives
Compared to conventional dairy or even regular grass-fed dairy, high-altitude cheeses offer higher C15 density. Compared to supplementation, it provides a whole-food matrix but also comes with even-chain saturated fats.
In Sardinia … grass-eating sheep and goats at high altitude … resulting in … cheese … has 50% more C15 in it compared to other dairy fats.
Book summarizing the entire C15 story, the discovery, mechanisms, evidence, and protocols. Recommended as a one-stop reference for the rapidly growing body of research.
DisclosureAuthored by Dr. Stephanie Venn-Watson, the book serves as a comprehensive resource on C15 science, its discovery, and practical applications.
The book covers the dolphin discovery, essential fatty acid criteria, mechanism of action (AMPK, mTOR, endocannabinoid system), the Biomat head-to-head with rapamycin and metformin, the five geroprotector must-haves, dietary sources, clinical trial data, and testing/supplementation guidance. Dr. Venn-Watson wrote it because new papers appear every 3–4 weeks, making it hard for even informed consumers to keep up. Host Ben Greenfield calls it a 'fascinating book' and promotes it alongside the supplement.
vs alternatives
More comprehensive than scattered PubMed searches; written by the lead researcher.
Personal experience
Ben Greenfield read the book and decided to trial C15 supplementation based on it.
It's really hard to keep up with the latest C-15 studies. Literally every 3 to four weeks there's a new paper coming out … which is one reason for writing the book, right? To have one resource for for all of these studies.
Lines worth pulling out — contrarian, specific, or perfectly phrased
6 items
We showed that C-15 is not only a beneficial and active saturated fat but that it was meeting these rare criteria of being an essential fatty acid.
The central claim of the episode, that a saturated fat can be essential, is a paradigm shift in nutrition science.
Nick said, 'Steve, like C-15 is the evidence I'm seeing is that C-15 is emerging as a ger protector.' … A ger protector is the holy grail of a longevity molecule because it slows the rate at which we age to stem the onset of the diseases that kill us.
Endorsement from the head of NIH’s longevity consortium, framing C15 as superior to existing anti-aging interventions.
This PDC was the second so the second ever discovered which then helped explain aha deeper sleep calmer mood less joint pain all of which I have experienced myself.
Reveals the discovery of a new endocannabinoid from C15, connecting a dietary fat directly to the brain’s cannabinoid system and explaining rapid subjective benefits.
For every 50% incremental increase in C-15 the percentage that we have in our … blood decreases our risk of type 2 diabetes by 8% and … coronary heart disease by 17%.
Provides specific, large-effect epidemiological numbers that make the case compelling.
We have over a 95% monthly retention rate and it's not because you know people are just crossing their fingers and believing … they're seeing and feeling benefits within months.
A bold commercial statement, but also hints that users subjectively experience noticeable improvements quickly.
Maybe what we've needed to support our longevity is you know C-15 again what all mammals get and we've been taking out of our diets by reducing the amount of dairy fat we eat.
Simplifies the narrative: a nutrient we used to get plenty of has been systematically removed, and we are now paying the price with modern chronic disease.
Sign in to share feedback
Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.
Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.
Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.